N-Heteroaryl glycinamides and glycinamines as potent NPY5 antagonists

This publication has 18 references indexed in Scilit:

• Modulation of neuropeptide Y receptors for the treatment of obesity
  Expert Opinion on Therapeutic Patents, 2009
• The Novel Neuropeptide Y Y5 Receptor Antagonist Lu AA33810 [N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] Exerts Anxiolytic- and Antidepressant-Like Effects in Rat Models of Stress Sensitivity
  The Journal of Pharmacology and Experimental Therapeutics, 2009
• Plasma Neuropeptide Y Concentrations in Combat Exposed Veterans: Relationship to Trauma Exposure, Recovery from PTSD, and Coping
  Biological Psychiatry, 2006
• Molecular evolution of NPY receptor subtypes
  Neuropeptides, 2004
• [D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆
  Peptides, 2000
• Role of the Y5 neuropeptide Y receptor in feeding and obesity
  Nature Medicine, 1998
• A receptor subtype involved in neuropeptide-Y-induced food intake
  Nature, 1996
• Neuropeptide Y (NPY) May Integrate Responses of Hypothalamic Feeding Systems and the Hypothalamo‐Pituitary‐Adrenal Axis
  Journal of Neuroendocrinology, 1995
• Synthesis and hypertensive activity of neuropeptide Y fragments and analogs with modified N- or C-termini or D-substitutions
  Journal of Medicinal Chemistry, 1989
• Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
  Nature, 1982